Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Kirkpatrick

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imagingBrahma D Natarajan, Christel N Rushing, Michael A Cummings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2012
Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancerDavid S Yoo, John P Kirkpatrick, Oana Craciunescu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic PathwaysMichael T Milano, Jimm Grimm, Scott G Soltys, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
CNS Oncology|September 21, 2021
Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysisJennifer H Kang, Christa B Swisher, Evan D Buckley, et al.
Journal of Radiosurgery and SBRT|January 31, 2020
Predicting intracranial progression following stereotactic radiosurgery for brain metastases: Implications for post SRS imagingBrahma D Natarajan, Christel N Rushing, Michael A Cummings, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
The addition of bevacizumab to standard radiation therapy and temozolomide followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastomaJames J Vredenburgh, Annick Desjardins, David A Reardon, et al.
Advances in Radiation Oncology|February 27, 2023
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic RadiosurgeryDavid J Carpenter, Andrew T Fairchild, Justus D Adamson, et al.
Advances in Radiation Oncology|May 1, 2024
Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery CourseJim X Leng, David J Carpenter, Christina Huang, et al.
Cancer|January 24, 2020
Current multidisciplinary management of brain metastasesMichael J Moravan, Peter E Fecci, Carey K Anders, et al.
Practical Radiation Oncology|May 24, 2016
Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice GuidelineAlvin R Cabrera, John P Kirkpatrick, John B Fiveash, et al.
International Journal of Radiation Oncology, Biology, Physics|June 4, 2013
Concurrent stereotactic radiosurgery and bevacizumab in recurrent malignant gliomas: a prospective trialAlvin R Cabrera, Kyle C Cuneo, Annick Desjardins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2012
Prospective trial of synchronous bevacizumab, erlotinib, and concurrent chemoradiation in locally advanced head and neck cancerDavid S Yoo, John P Kirkpatrick, Oana Craciunescu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2018
Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic PathwaysMichael T Milano, Jimm Grimm, Scott G Soltys, et al.
Pageof 16